TWO · Healthcare

Gongwin Biopharm Holdings Co. Ltd. (6617)

Biotechnology

Gongwin Biopharm Holdings Co. Ltd. (6617) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6617

P/E ratio

25.00

Gongwin Biopharm Holdings Co. Ltd. (6617) — FAQ

What is 6617's P/E ratio?

The price-to-earnings (P/E) ratio for Gongwin Biopharm Holdings Co. Ltd. (6617) is 25.00 (data as of 2026-05-23).

Does Gongwin Biopharm Holdings Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Gongwin Biopharm Holdings Co. Ltd. (6617). Check the MyAverix Finance app for the latest dividend data.

What sector is Gongwin Biopharm Holdings Co. Ltd. in?

Gongwin Biopharm Holdings Co. Ltd. (6617) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6617 listed on?

6617 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)